Reduction of wavelength discrimination ability in the 560--640 nm range, but not in the 404-540 nm range, has been demonstrated in goldfish after intravitreal injection of Dl-dopamine receptor antagonists. Intravitreal injection of the dopaminergic neurotoxin 6-OH-dopamine severely reduced wavelength discrimination ability in the 540-661 nm range within 3 days. Discrimination ability could be reconstituted by the Dl-agonist SKF 38393. Animals recovered from injection of 6-OH-dopamine within 14-16 days. No change of wavelength discrimination was induced by 6-OHdopamine in the 461-540 nm range. We conclude that under photopic conditions dopamine modulates retinal mechanisms involved in red-green colour coding via Dl-dopamine receptor-like binding sites.
INTRODUCTION
Investigation of colour vision in fish has a long tradition.
von Frisch (1913) demonstrated in training experiments that the minnow (Phoxinus laevis) is able to discriminate blue, green and red from any given grey. Schiemenz (1924) and Wolff (1925) found UV-vision while measuring wavelength discrimination, and Burkamp (1923) had already showed colour constancy. More recently, investigators have measured spectral sensitivity mainly in goldfish using different behavioural techniques, such as classical conditioning (Yager, 1967) , optomotor response (Cronly-Dillon & Muntz, 1965) , heart rate conditioning (Beauchamp & Rowe, 1977) and dorsal light reaction (Powers, 1978) . Evidence for the existence of three cone types was obtained in carp by intracellular recording (Tomita, 1963) and in goldfish by microspectrophotometry (Marks, 1965) . The cones revealed maximal sensitivities at about 450 nm (S-cone), 530 nm (M-cone), and 625 nm (L-cone). A fourth, UVsensitive cone type has been concluded from behavioural experiments in goldfish (Neumeyer, 1985; Hawryshyn & Beauchamp, 1985) . This fourth cone type was also detected by microspectr.ophotometry in other cyprinids (Avery et al., 1983; H~irosi & Hashimoto, 1983; Hashimoto et al., 1988; Bowmaker et al., 1991; Hawryshyn & H~irosi, 1991 Experiments with freely swimming goldfish using a forced two-choice discrimination method showed a spectral sensitivity function with four maxima in the UV, short, middle and long wavelength range in goldfish (Neumeyer, 1984; Fratzer et al., 1994) . All four cone types, UV-, S-, M-, and L-cones, contribute to colour vision as shown in colour mixture experiments (Neumeyer, 1985 (Neumeyer, , 1992 . Wavelength discrimination was investigated under different illumination conditions. Under photopic conditions of 20-25 Ix, three ranges of highest discrimination ability around 400, 500 and 600 nm were found, and colour vision was shown to be tetrachromatic (Neumeyer, 1986 (Neumeyer, , 1992 . Under reduced illumination conditions of about 1 Ix, however, wavelength discrimination in the 550-660 nm range was impaired and colour vision was trichromatic (Neumeyer & Arnold, 1989) . As spectral sensitivity in the long wavelength range was reduced by about 1 log unit, Neumeyer and Arnold (1989) proposed that the L-cone type does not contribute to colour vision under these (1 Ix) conditions. Adaptation-dependent changes in colour vision inferred from behavioural results might be analogous to changes in the physiology of retinal neurons. Horizontal and ganglion cells change their chromatic response characteristics and/or their connectivity during light adaptation (see Negishi et al., 1990 and Wagner, 1992 for reviews; Raynauld et al., 1979) . Changes in the chromatic response properties of horizontal cells seem to be mediated, at least in part, by dopamine. Superfusion of retinae with dopamine antagonists, e.g. haloperidol and SCH 23390, prevents both the transition from monophasic to biphasic responses of H2-4036 c. MORA-FERRER and C. NEUMEYER horizontal cells, as well as the formation of spinules (finger-like protrusions from horizontal cell dendrites) during light adaptation (Djamgoz et al., 1989; Kirsch et al., 1991; Weiler et al., 1988a,b) . The effect of SCH 23390, a specific Dl-antagonist, indicates that D1-receptors are located on horizontal cells (Behrens & Wagner, 1995; Kirsch et al., 1991; Watling et al., 1979) . This is also supported by autoradiographic experiments with 3H-SCH 23390 (Yazulla & Lin, 1995) . Finally, dopamine release has been shown to be highest at predawn, remaining high during subjective day and low at night . This supports the idea of dopamine as a light-adaptive signal in the fish retina (see Kolbinger et al., 1990; Kohler et al., 1990; Djamgoz & Wagner, 1992 for review).
According to Djamgoz and Wagner (1992) , dopamine is necessary to achieve the light-adapted state of the retina. At reduced illumination conditions of 1 Ix, wavelength discrimination is possible in the violet and blue-green ranges, whereas red-green discrimination requires the light-adapted state (Neumeyer & Arnold, 1989) . This might imply that the light-adaptive effect of dopamine and the ability of "red-green" discrimination are interconnected. This was confirmed in earlier training experiments: after intravitreal injection of haloperidol, a relatively non-specific dopamine antagonist, an impairment of discrimination ability in the red-green spectral range, but not in the violet-blue-green range was observed (Mora-Ferrer & Neumeyer, 1993 . In this paper, we investigated whether dopamine, particularly via Dl-dopamine receptors, is important for wavelength discrimination by determining: (1) the effect of specific Dl-antagonist on wavelength discrimination in the 404-661 nm range; (2) the long-term effect of retinal dopamine depletion in the 461-661 nm range; (3) the time course of recovery from retinal dopamine depletion; and (4), the possible reversal of dopamine depletion by treatment with a specific Dl-agonist.
MATERIALS AND METHODS

Animals and training procedure
Goldfish (Carassius auratus, 8-12 cm body length) were obtained from local suppliers. Single animals were kept in aerated glass tanks (40 × 25 × 22 cm) at room temperature. Fish were housed under fluorescent light on a cycle of 12 hr light, 12 hr dark with light onset at 8 a.m. (180--200 lx at water level, fluorescent tubes: Osram-L, 40W/19, daylight 5000 de luxe). The white room illumination during training and experimental sessions was reduced to 20 lx at water level (Neumeyer, 1984) . Fish were fed during training periods with a food paste (Neumeyer, 1984) , and with dry flake food (Sera, Germany) when intervals of more than 1 day occurred between training periods.
Goldfish were trained to discriminate light of different wavelengths as previously described (Neumeyer, 1986) . In brief: food rewards were delivered through tubes which ended directly above the two test fields (2 cm dia., 10 cm apart). When the fish approached the test field illuminated with light of the training wavelength they were rewarded. Light of various wavelengths was projected onto test fields through glass fibre guides (Schott and Gen., Mainz, Germany) using slide projectors (Leitz Prado Universal, 250 W). Rotation of the fibre optics exchanged the stimulus positions. Monochromatic light was obtained using interference filters (Schott and Gen., type DIL, half-band width 6-15 nm). Light was attenuated with neutral density filters (Schott, type NG).
In the tests for wavelength discrimination, a reward was given at the training stimulus only after 25 bites at both test fields. Then, the test fields were occluded, and after 30-60 sec the stimuli were presented in exchanged positions. From 100 choices, i.e., bites at the test fields, the relative choice frequency of the training stimulus was calculated. A maximum of 10 min time was allowed for each discrimination experiment consisting of 100 choices. The number of photons at each wavelength was adjusted to equal "goldfish subjective brightness" according to the spectral sensitivity function measured under the same conditions (Neumeyer, 1984) . Fish could, therefore, only discriminate between presented stimuli on the basis of hue, and not brightness.
The three training wavelengths, 404, 495 or 599 nm, were chosen from ranges with best wavelength discrimination (Neumeyer, 1986 ). These wavelengths were tested against longer (404 nm: 430, 461 nm) or shorter and longer wavelengths (495 nm: 461,520, 540 nm; 599 nm: 540, 555, 570, 615, 640, 661 nm) . After fish had consistently achieved more then 80% correct choices for several days, drug-injection experiments were performed. Data obtained pre-and post-injection were compared to the A2 values (describing the minimal discriminable distance between two wavelengths) measured by Neumeyer (1986) . To obtain A2 a threshold criterion of 70% relative choice frequency was used. As a measure of changes in discrimination ability due to intravitreal injection, the "interception" wavelengths at which the 70% relative choice frequency criterion were achieved, were compared for the control and experimental conditions. An increase of A2 (training wavelength + interception wavelength) after injection was interpreted as a reduction in discrimination ability.
Injections
All injections were performed using a Hamilton syringe series 700 (needle gauge 26, Aldrich, Germany) into the vitreous of both eyes after opening the sclera at the upper rim with a blood lancet. Control injections consisted of 10/~1 phosphate buffer (0.1 M, pH 7.4) or 10 #1 of fish Ringer (all chemicals from Sigma, Miinchen, Germany; in mM: MgC1 0.5; CaC1 2.5; glucose 10; ascorbic acid 0.1; NaC1 90 and KC1 2.5; pH 7.4). The volume of all other injections was 5 pl. Injections were performed between 10 a.m. and noon. Injected concentrations are given in Training wavelength 599 nm. Data before, 2 hr after, and during several days after injection of 10 #1 fish Ringer. Ordinate: relative frequency (%), with which the training wavelength was chosen; abscissa: wavelength (nm) given for comparison in the two-choice discrimination task. The data point at the training wavelength (599 nm) was assumed to be 50%, i.e., presenting two identical stimuli should result in identical choice frequencies for both stimuli. Mean values preinjection [11, n=4-7, plus standard deviation (SD)], 2hr postinjection (O, n = 2-4, minus SD), and during several days after injection (A). Data from Neumeyer (1986) , ~) are given for comparison. Arrows indicate interception wavelengths, i.e., interpolated closest wavelengths, whi~ch an independent control fish could discriminate from the training wavelength 599 nm.
injected concentrations. 6-OH-dopamine (6-OHDA; Sigma, Mfinchen, Germany), a dopaminergic neurotoxin which reportedly destroys retinal dopaminergic interplexiform cells (Negish:i et al., 1982a) , and the D1-agonist SKF 38393 (RBI, K61n, Germany) were dissolved in distilled water and diluted to final concentration. All injections with dopamine antagonists and D1-agonist were conducted after at least 1 hr of dark adaptation under dim red light. Animals remained in complete darkness for a further 30 rain to decrease competitive binding of injected drug and dopamine. 6-OHDA was injected into light-adapted fish only. Except for one fish, all animals treated in the 540--661 nm range received one injection of 6-OHDA, one fish trained in the 540-661 nm range and all fish tested in the 460-540 nm range received two injeelfions (Negishi et al., 1982a) . In order to obtain comparable concentrations at retinal level and to avoid excessive dosage, the drug concentrations in injected solutions had to be estimated for each individual animal. Several simplifications were made: the eye of the fish was assumed to be homogeneous, the volume of the lens was ignored, probable loss of injected substance by leakage through the injection site or transport was assumed to be minimal. An individual diluting factor (injected volume/eye volume) was calculated for each fish in order to calculate the concentration of the solution to be injected.
No fish showed any obvious change in behaviour after injection of any of the drugs used. The time necessary to make 100 choices remained unchanged for all tested fish, i.e., no change in motor behaviour or swimming activity could be observed. All injection experiments were approved by the Council of Ethics and Animal Experiments of the University of Mainz.
Tests after injection
After injection of Dl-antagonists or the Dl-agonist, fish were kept for a further 30 min in complete darkness. They were then light-adapted and measurements were performed for a maximum of 90 min. The time limit of 90 min was set to prevent a possible loss of efficiency of the injected drug due to degradation, transport or any other mechanism (pers. observation, data not shown). This is supported by Lin and Yazulla (1994) , who reported a wearing off of dopaminergic drugs in goldfish within 90--120 min after intravitreal injection. Animals injected with 6-OHDA were tested in the same way as normal, uninjected animals. Fish injected with 6-OHDA and trained at 495 nm were tested for 6-12 days; fish trained at 599 nm were tested for 8-20 days after injection. Dl-agonist SKF 38393 was injected 6-9 days after injection of 6-OHDA in animals trained at 599 nm.
One major problem in data acquisition was the limited time after injection. As only 90 min were used for measurements, each taking up to 10 min, the number of measurements depended on the performance of individual fish and the number of combinations between training and test wavelengths. Measurements of more than 10 min duration were excluded from analysis.
Light measurements
All measurements were performed with a radiometer/ photometer (EG and G 550 or EG and G DR 1600 using the detector D 100-$2, Gamma Scientific, San Diego, U.S.A.). Monochromatic light was measured in mW/cm z, the white room illumination in lx. 
Statistical analysis
Variations of data distribution were observed due to different combinations of training and test wavelengths and treatments. In order to compare data obtained with individual animals pre-and post-injection as well as between pooled data from several animals pre-and postinjection the Mann-Whitney Rank Sum Test was applied. Two different sets of data were analysed to answer the following questions: (1) Is there any statistical difference between data obtained for a specific pair of training-and test-wavelength, e.g. 599 and 640 nm, pre-and postinjection of the Dl-antagonist or 6-OHDA? (2) Is there any difference between data obtained for a specific wavelength combination after injection of 6-OHDA, and before and after injection of the Dl-agonist?
RESULTS
Control experiments
Control experiments were performed to test for shortterm (less then 2 hr) and long term (1-5 days) effects of intraocular injections. Fish (n = 5) were trained at light of 599 nm and tested against light of wavelengths 570 and 630 nm. Fish were injected with 10 pl of fish Ringer or phosphate buffer into both eyes. The results of one fish are shown as an example (Fig. 1) . Data pre-injection exceeded 84% correct choices. These data are very similar to data obtained by Neumeyer (1986) using more test wavelengths. A connecting line between the data obtained for test and training wavelengths results in very similar v-shaped graphs. The extrapolated interception wavelengths from Neumeyer (1986) , 576 and 617 nm, were slightly, but not significantly different from the preinjection control. Data obtained about 2 hr after injection, or data obtained during 1-5 days after injection, were not different from control or the independent control data from Neumeyer (1986) . We conclude that intravitreal injections per se did not affect wavelength discrimination ability during both short-and long-term experiments.
Injection of D l-antagonists
Wavelength discrimination in the range 540--661 nm.
Three fish received intravitreal injections of the specific Dl-receptor antagonist SCH 23390 and one fish of the specific Dl-antagonist SKF 83566-biotinyl. All fish were trained at light of 599 nm and tested against light of shorter and longer wavelengths. Mean values and standard deviations (SD) are shown for one fish as an example (Fig. 2) . All post-injection data differed significantly from pre-injection data (P< 0.016). The largest observed change in wavelength discrimination ability was in the 570-640 nm range, ranging up to a 28% loss of relative choice frequency. This reduction results in a widening of the v-shape of the graph, indicating an increase of interception wavelength of about 24 nm in the long wavelength range to 643 nm and a 31 nm increase in the mid wavelength range to 551 nm (Fig. 2, arrows) . For comparison see interception wavelengths from Fig. 1 derived from independent experiments: 576 and 617 nm ( Fig. 1, arrows ; data from Neumeyer, 1986) . Intraocular injections with Dl-antagonists reduced relative choice frequencies in the whole tested spectral range in all four animals tested. The greater the distance between test and training wavelengths, the smaller was the effect of Dl-antagonists on wavelength discrimination ability (Fig. 3 ). Significant differences between preand post-injection data were found for all tested wavelengths except 540 nm (555, 570, 615, 640 and 661nm: P<0.025 ). Interception wavelengths were shifted 23 and 26 nm to shorter and longer wavelengths (Fig. 3, arrows) . 
Wavelength discrimination in the 461-540 nm range.
Three animals were trained at 495 nm and tested against shorter and longer wavelengths. All animals received intravitreal injections of SCH 23390. As all experiments gave similar results, pooled data are shown (Fig. 4) . Only data obtained, post-injection, with test wavelength 540 nm differed significantly from data obtained preinjection (P= 0.003). Data obtained with test wavelengths 461 and 520 nm showed no difference, indicating that neither injection nor handling had any effect on discrimination ability. Furthermore, the lack of any pharmacological or other effect became obvious regarding the very small estimated change of 2-4 nm in interception wavelength. Therefore, we conclude that SCH 23390 did not impair discrimination ability in the wavelength range tested.
Wavelength discrimination in the 404--464 nm range.
Experiments with three animals were performed in the 404-461 nm range (Fig. 5) . Data, obtained with test wavelength 434 nm, were significantly different from data obtained pre-injection (P = 0.035) but only a 5 nm increase in interception 'wavelength was found.
Wavelength discrimination after injection of the dopaminergic neurotoxin 6-OH-dopamine and the D l-agonist SKF 38393
Wavelength discrimination in the 540-661 nm range.
Five fish were injected intravitreally with 6-OHDA after training and tested up to 20 days after injection. Four out of five fish also received intravitreal injection of the D1-agonist SKF 38393 at different days after injection of 6-OHDA. Data are plotted either as time-frame choicefrequency diagrams or as mean values pre-against postinjection of 6-OHDA, and post-6-OHDA against post-SKF 38393. A time-frame relatiw~ choice-frequency diagram of one fish, as an example (Fig. 6) , demonstrates the effect of 6-OHDA and SKF 38393 on wavelength discrimination ability in the 540-661 nm range. While relative choice frequency dropped within 7 days of 6-OHDA injection to 70% and below, injection of the Dl-agonist transiently restored wavelength discrimination to control levels (Fig. 6, arrow) . By 16 days after 6-OHDA injection, wavelength discrimination recovered completely. In contrast to experiments with Dl-antagonist, the effect of 6-OHDA uniformly reduced relative choice frequencies below 70% for all wavelengths tested. In order to compare experiments after injection of 6- OHDA and SKF 38393 with the ones after injection of Dl-antagonists, data were plotted as mean values pre-vs post-injection. Data from another fish were given as an example (Fig. 7) . Relative choice frequencies never reached the threshold criterion of 70% (days 1-8) after injection of 6-OHDA. Two wavelengths (640 and 661 nm) were tested at 1-1.5 log units higher intensities in addition to the usual intensities (Fig. 7, solid  diamonds) . The increased light intensity of test wavelengths did not improve wavelength discrimination. In contrast, the relative choice frequencies, after injection of SKF 38393, were very similar to those obtained before 6-OHDA injection. As a result, the ability to discriminate wavelengths, in terms of interception wavelengths, were identical for post-SKF 38393 and pre-6-OHDA treated animals ( Fig. 7, arrows) . The impairment of wavelength discrimination ability was uniform for the whole tested spectral range, independent of the intensity of the test wavelengths during the experiment. The time-frame of the relative choice frequency diagram for all five fish demonstrates how quickly wavelength discrimination was affected by 6-OHDA (Fig. 8) . Within 1 day, the relative choice frequency dropped, reaching a minimum of 65% correct choices by day 4. Recovery was apparent at day 10, obvious at day 13 and by day 16 there was recovery to control performance. The effect of 6-OHDA was uniform in the 540-661 nm range and recovery was uniform for all the wavelengths tested.
A comparison of data, pre-/post-6-OHDA and post-SKF 38393, shows how interception wavelengths were affected by the different drug treatments (Fig. 9) . While 6-OHDA reduced the average relative choice values below threshold (P< 0.001), injection of SKF 38393 induced a complete recovery to pre-6-OHDA-injection level (Fig. 9, arrows) . This was unexpected, as one would assume that injection and handling might lead to a slight decrease, but not an increase of the fish's ability, as observed in control experiments.
Wavelength discrimination in the 461-540 nm range. To investigate the effect of 6-OHDA in the 461-540 nm range, three fish received injections after training at wavelength 495 nm. Relative choice frequencies during 12 days post-injection varied between 72 and 97% (data not shown). Mean values of relative choice frequency were only slightly lowered and did not vary significantly from data prior to injection of 6-OHDA except for test wavelength 540 nm (P < 0.001; Fig. 10 ).
DISCUSSION
Behavioural experiments
We have shown that Dl-dopamine receptor antagonists or 6-OHDA cause impairment of red-green discrimination but not blue-green and violet-blue discrimination. Impairment of red-green discrimination was not the result of a change in motor activity as neither a prolonged duration of experimental sessions nor a disturbance in feeding activity was observed. In addition, the effect of 6-OHDA can be reversed by a Dl-dopamine receptor agonist. The apparent conclusion that red-green discrimination is dopamine-dependent is consistent with effects of dopamine amagonists on H2-type horizontal cells (Weiler et al., 1988a,b; Djamgoz et al., 1989; Kirsch et al., 1991) , the effect of haloperidol on goldfish wavelength discrimination (Mora-Ferrer & Neumeyer, 1993 , and observed disturbances in visual properties of Parkinson patient,; (see below). However, there are some problems with this simple conclusion: (1) 6-OHDA induces a more severe loss of wavelength discrimination ability than Dl-dopamine receptor antagonists. Destruction of dopaminergic interplexiform cells (DA-IPC) might have been more effective than competitive binding of Dl-dopamine antagonist and dopamine. (2) The effect of 6-OHDA is limited to about 13 days, after which wavelength discriminalion recovers to pre-injection levels. This recovery of wavelength discrimination occurs at the time DA-IPCs disappear due to 6-OHDA treatment (Negishi et al., 1982a) .
The first problem is the differential impairment of D1-antagonists and 6-OHDA-injection of discrimination in the mid and long wavelength range. Dl-antagonists reduce red-green discrimination ability (see Fig. 3 ), i.e., discrimination is still possible but wavelengths have to be farther apart. In contrast, 6-OHDA induces red-green blindness if the threshold criterion of 70% is applied (see Fig. 9 ). The simplest explanation for the differential effects is that competitive binding of antagonists to receptors following intravitreal injection is susceptible to a variety of effects including distribution, degradation, diffusion etc. that might lead to regional variations in dopaminergic inhibition. This is in contrast to the more global destruction of DA-IPC by 6-OHDA neurotoxicity. We suggest that the difference in effect of antagonists and neurotoxin is more likely to be quantitative rather than qualitative.
The second problem concerns the time course of the effect of 6-OHDA on wavelength discrimination in goldfish. 6-OHDA treated animals lost red-green discrimination within 1-3 days, while recovery of wavelength discrimination occurred within 14-16 days of 6-OHDA treatment. These effects are incompatible with the time course of DA-IPC degeneration and neogeneration following 6-OHDA injections (Negishi et al., 1982a (Negishi et al., ,b, 1990 Yazulla & Studholme, 1995) . At low doses of 6-OHDA injection, neurotoxic effects are specific for DA-IPCs, which disappear within 10-14 days after injection and reappear in a single row at the marginal zone at about 6 weeks. High doses of 6-OHDA intoxication cause a general neurotoxic effect throughout the retina and regeneration of neurones, including DAIPCs still takes about 6 weeks (Negishi et al., 1987 (Negishi et al., , 1990 for review). Therefore, goldfish lose wavelength discrimination in the "red-green" range while DA-IPCs are degenerating, but recover this ability by the time DAIPCs disappear. The chromatic responses of horizontal cells and the light-adaptive spinule formation of horizontal cell dendrites are inhibited following DA-IPC destruction (Teranishi et al., 1984; Yazulla & Studholme, 1995; Yazulla et al., 1996) . Since red-green discrimination recovers by the time DA-IPCs disappear, it is unlikely that horizontal cells contribute directly to red-green discrimination. The finding by Wietsma et al. (1995) that "red-green blind" ethambutol-treated goldfish possess horizontal cells with normal spinule/ribbon numbers and have chromatic responses, as found in untreated animals led to the same conclusion.
Does dopamine depletion affect spectral sensitivity?
Goldfish colour vision is tetrachromatic under photopic conditions but trichromatic under mesopic conditions (Neumeyer & Arnold, 1989) . Spectral sensitivity in the long wavelength range decreases by 1-1.5 log units at about 1 Ix. This raises the question whether the reduction of red-green discrimination caused by Dl-dopamine antagonists or dopamine depletion is mimicking the effect of mesopic backgrounds, i.e., a reduction of long wavelength sensitivity which could be compensated by an increase in the intensity of test wavelengths. Our data (see Fig. 7 , solid diamonds, and Fig. 9, open hexagons) showed that an increase of 1-1.5 log unit in light intensities of test wavelengths 640 and 661 nm did not improve wavelength discrimination. Furthermore, loss of spectral sensitivity in the long wavelength range, as shown for mesopic adaptation conditions, would result in different subjective brightness of test and training wavelengths and, therefore, offer animals the possibility to discriminate on the basis of brightness instead of hue. Such a discrimination behaviour, based on an intensity criterion instead of hue, was not observed. From this we conclude, although we did not measure the spectral sensitivity after dopamine depletion, that a loss of spectral sensitivity is unlikely to be the reason for the loss of red-green discrimination. As in the case of 1 lx, we assume that dopamine depletion does not affect the L-cones themselves, but their contribution to the chromaticity channel . This is supported further by an increase in perceived brightness, measured with the dorsal light reaction, that has a maximum sensitivity in the long wavelength range (Powers, 1978) after 6-OHDA treatment (Lin & Yazulla, 1994) .
Pharmacological treatment affects the mid to long wavelength range only
In contrast to the 540-661 nm range, changes in discrimination ability in the 404-540 nm range were minor or non-existent, independent of the dopaminergic drug used. These results are in line with data obtained with the non-specific dopamine antagonist haloperidol (Mora-Ferrer & Neumeyer, 1993 . Previous reports have shown an exclusive susceptibility of red-green discrimination and spectral sensitivity in the long wavelength range to ethambutol Neumeyer et al., 1991) and the GABAa antagonist bicuculline . These reports and our data indicate that the "red-green system" acts in a pharmacologically different way from other colour channels. The retinal "coding" of other colours such as UV, blue or green might be located in different neuronal pathways such as blue-encoding double colour-coded bipolar cells (Kaneko & Tachibana, 1981) and/or ganglion cells (Daw, 1967; Kamermans et al., 1989; Mackintosh et al., 1987; Beauchamp & Lovasik, 1973) . outer and inner retina. Furthermore, RNA-RNA in situ hybridization experiments, using a human dopamine Dla-receptor derived clone, in goldfish retina indicate localization of Dl-receptors on cones, amacrine cells and ganglion cells (Mora-Ferrer et al., 1996) . Thus, it is not possible to isolate a specific cell type that is responsible for the Dl-receptor-mediated modulation of red-green discrimination.
Studies of dopaminergic deficits or treatments of visual abilities in higher vertebrates
Parkinson's disease, a degenerative destruction of dopaminergic neurones in the CNS (Cedarbaum & Schleifer, 1991 for review) not only affects motor but also visual abilities. Changes in the ability of naming coloured objects with the appropriate "colour" have been reported (Biittner et al., 1993) as well as abnormal results in the Farnsworth-Munsell 100 hue test (Biittner et al., 1994; Price et al., 1992) . Measurements of visual-evoked potentials, ERGs and psychophysical tests also demonstrated a loss in contrast sensitivity and low spatial frequency detection (Bodis-Wollner, 1988; Regan & Maxner, 1987; Hutton et al., 1991) . Several of these impairments can be alleviated with L-DOPA, a common medication for Parkinson's disease (Hutton et al., 1993; BiJttner et al., 1994; Bodis-Wollner & Tagliati, 1993) . In contrast to the reported experiments with goldfish, disturbances of colour vision were found both along the blue-yellow and the red-green axis (Price et al., 1992; Biittner et al., 1994) .
More recent experiments in goldfish indicate that intravitreal injection of 6-OHDA or a D2-dopamine receptor antagonist decreased motion sensitivity, as measured with an optomotor response behaviour . As goldfish have been used recently to investigate motor defects in parkinsonism induced by MPTP (1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine) (Pollard et al., 1992) , and retinal dopamine depletion induces somewhat similar effects in goldfish and human, investigation of dopaminergic mechanisms in fish retina might help to elucidate analogue mechanisms in higher vertebrate retinae.
Dl-dopamine receptor localization and wavelength discrimination
Injection of the dopamine Dl-receptor agonist SKF 38393 into 6-OHDA treated animals resulted in a complete but temporary recovery of wavelength discrimination ability. This effect must have been mediated by a dopamine Dl-receptor or a dopamine Dl-receptorlike binding site. Pharmacological experiments in fish have shown dopamine Dl-receptor-like mediated responses on horizontal cells (Kirsch et al., 1991; Watling et al., 1979) and bipolar cells (Heidelberger & Matthews, 1994) . These data are supported by recent antagonist binding experiments using SCH 23390-bodypi (Behrens & Wagner, 1995) and [3H]SCH 23390 (Yazulla & Lin, 1995) labelling that demonstrate specific binding in both
CONCLUSION
Retinal dopamine is important in providing correct wavelength discrimination in the 540-661 nm range in goldfish. This effect is mediated by Dl-dopaminereceptor-like binding sites. The distribution of D1-receptors indicates that both inner and outer retinal cells are involved. As the effect of dopamine depletion is transient and wavelength discrimination ability recovers within 14-16 days after injection of 6-OH-dopamine, while DA-IPC are not functional, it remains unclear how short-term and long-term disruption of dopaminergic function are involved in coding of chromatic information, and which and whether other mechanisms are involved. Horizontal cells do not seem to be crucial in red-green discrimination.
